Google DeepMind CEO Demis Hassabis envisions AI eradicating all diseases within a decade, potentially revolutionizing drug ...

GenAI offers a realistic path forward in tackling previously undruggable targets, with the potential to reshape the entire ...

The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its ...

Researchers at Duke University School of Medicine hack cell entry to supercharge cancer drugs: Durham, North Carolina Monday, April 21, 2025, 17:00 Hrs [IST] A new discovery could ...

Artificial intelligence (AI)-based drug developer Isomorphic Labs said it has raised $600 million in its first external funding round, with the proceeds expected to accelerate its research and ...

these studies emphasize the critical role of molecular and structural understanding in advancing drug design and development. Lycorine derivatives, including Ly-8, were designed and synthesized to ...

New center will use cutting-edge AI to accelerate the creation of life-saving medicines AI Small Molecule Drug Discovery Center Photo 1 Left to Right: Ethan Grimes, BS, and Paul Morgan, MD, conduct ...

The AI-first drug design and development company plans to utilize the investment to advance its AI drug design engine, enhance software capabilities, finance drug development programs, and ...

The funding will accelerate further development of Isomorphic’s AI drug design engine and support the company’s goal of bringing its discovered drugs to clinical trials. Isomorphic Labs was ...

Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross ...